24 August 2017 1 Min Read
Blue Label shareholders to get dividend, despite R5.5bn Cell C deal
Revenue was flat but profit increased, despite losses from its subsidiaries in India, Mexico and Mauritius
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In